Neurosense Therapeutics (NRSN) CEO Issues Q3 2023 Update
Go back to Neurosense Therapeutics (NRSN) CEO Issues Q3 2023 Update| (NASDAQ: NRSN) | Delayed: 0.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.47 | 52 Week High | $ | |||
| Open | $0.47 | 52 Week Low | $ | |||
| Day High | $0.47 | P/E | N/A | |||
| Day Low | $0.47 | EPS | $ | |||
| Volume | 45,789 | |||||

